MD - CIK 0000893949
The table below shows Pediatrix Medical Group, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $476.20M | $492.88M | $468.84M | $458.36M | $511.16M | $504.30M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Pediatrix Medical Group, Inc. reported annual revenue of $1.91B for fiscal year 2025. That is down 4.9% from $2.01B in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $3.18B (FY 2016) to $1.91B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $60.27M |
| $60.79M |
| $55.71M |
| $58.60M |
| $58.12M |
| $56.56M |
| Operating income | $41.66M | $68.05M | $59.87M | $32.10M | $33.83M | -$157.72M |
| Income tax | $9.27M | $16.07M | $15.71M | $7.35M | $5.79M | -$14.70M |
| Net income | $29.57M | $71.71M | $39.26M | $20.74M | $19.44M | -$153.03M |
| EPS (diluted) | $0.36 | $0.84 | $0.46 | $0.24 | $0.23 | -$1.84 |